学術業績・賞など

2025年の学位論文や研究活動レポートなど、当グループの実績をお知らせします。

2025

3月19日 服部教授が共著の論文がRespiratory Investigationに掲載されました。

Respir Investig. 2025 Mar 17;63(3):365-372. doi:10.1016/j.resinv.2025.02.009.
Prognostic prediction for newly diagnosed patients with idiopathic interstitial pneumonia: JIPS Registry (NEJ030)
Ryo Okuda, Takashi Ogura, Shu Hisata, Tomohisa Baba, Yasuhiro Kondoh, Takafumi Suda, Takeshi Johkoh , Tae Iwasawa, Hiromi Tomioka, Masashi Bando, Arata Azuma, Yoshikazu Inoue, Nobuhisa Ishikawa, Naoki Arai, Takahisa Takihara, Megumi Hamaguchi, Toru Arai, Yutaro Nakamura, Atsushi Miyamoto, Keisuke Tomii , Yasunari Miyazaki, Hirofumi Chiba, Haruyuki Ishii, Naoki Hamada, Yasuhiro Terasaki, Junya Fukuoka, Fumikazu Sakai, Ryoko Egashira, Kiminori Fujimoto, Hiromitsu Sumikawa, Takuji Suzuki, Susumu Sakamoto , Yasuhiko Nishioka, Noboru Hattori, Naozumi Hashimoto, Satoshi Morita, Nao Ichihara, Hiroaki Miyata, Koichi Hagiwara, Kunihiko Kobayashi, Toshihiro Nukiwa; JIPS registry collaborators.


3月18日 山口先生が共著の論文がTherapeutic Advances in Medical Oncologyに掲載されました。

Ther Adv Med Oncol. 2025 Mar 15:17:17588359241312503. doi:10.1177/17588359241312503.
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study
Fumihiko Kinoshita, Shigeru Tanzawa, Toshihiro Misumi, Hiroshige Yoshioka, Eisaku Miyauchi, Kiichiro Ninomiya, Yasunori Murata, Masafumi Takeshita, Masafumi Yamaguchi, Shunichi Sugawara, Yosuke Kawashima, Kazuki Hashimoto, Masahide Mori, Akihiko Miyanaga, Anna Hayashi, Hisashi Tanaka, Ryoichi Honda, Masafumi Nojiri, Yuki Sato, Ken Yamamoto, Ken Masuda, Toshiyuki Kozuki, Takahisa Kawamura, Takuji Suzuki, Teppei Yamaguchi, Kazuhiro Asada, Satoshi Tetsumoto, Hiroshi Tanaka, Satoshi Watanabe, Yukihiro Umeda, Kakuhiro Yamaguchi, Shoichi Kuyama, Kosuke Tsuruno, Yuki Misumi, Hiroshi Kuraishi, Ken Yoshihara, Akira Nakao, Akihito Kubo , Toshihiko Yokoyama, Kana Watanabe, Nobuhiko Seki.


3月17日 北台先生の論文がLungに掲載されました。

Lung. 2025 Mar 12;203(1):43. doi:10.1007/s00408-025-00800-y.
Serum Soluble Toll-Like Receptor 4 is a Predictive Biomarker for Acute Exacerbation and Prognosis of Idiopathic Pulmonary Fibrosis: A Retrospective Study
Erika Kitadai, Kakuhiro Yamaguchi, Hiroshi Iwamoto, Kiyofumi Shimoji, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Shinichiro Ohshimo, Hironobu Hamada, Noboru Hattori.


3月14日 益田先生が共著の論文がLung Cancerに掲載されました。

Lung Cancer. 2025 Jan. doi:10.1016/j.lungcan.2024.108056.
Long-term outcome of chemoimmunotherapy for extensive-stage small-cell lung cancer according to key clinical trial eligibility: 3-year outcomes from a prospective cohort study
Jun Sugisaka, Daichi Fujimoto, Motohiro Tamiya, Akito Hata, Hirotaka Matsumoto, Toshihide Yokoyama, Yoshihiko Taniguchi, Junji Uchida, Yuki Sato, Takashi Kijima, Hisashi Tanaka, Naoki Furuya, Takeshi Masuda, Yoshihiko Sakata, Eisaku Miyauchi, Go Saito, Satoru Miura, Teppei Yamaguchi, Haruko Daga, Shinya Sakata, Nobuyuki Yamamoto, Hiroaki Akamatsu.


2月28日 平川先生の論文がCancersに掲載されました。

Cancers. 2025 Feb 7. doi:10.3390/cancers17040572.
Predictive Value of Circulatory Total VEGF-A and VEGF-A Isoforms for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Patients with Non-Small-Cell Lung Cancer
Tetsu Hirakawa, Kakuhiro Yamaguchi, Kunihiko Funaishi, Kiyofumi Shimoji, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Hiroshi Iwamoto, Hironobu Hamada, Shingo Yamada, Noboru Hattori.


2月19日 山口先生が共著の論文がTherapeutic Advances in Medical Oncologyに掲載されました。

Ther Adv Med Oncol. 2025 Feb 14. doi:10.1177/17588359251318850.
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study
Shigeru Tanzawa, Hiroshige Yoshioka, Toshihiro Misumi, Eisaku Miyauchi, Kiichiro Ninomiya, Yasunori Murata, Masafumi Takeshita, Fumihiko Kinoshita, Takatoshi Fujishita, Shunichi Sugawara, Yosuke Kawashima, Kazuki Hashimoto, Masahide Mori, Akihiko Miyanaga, Anna Hayashi, Hisashi Tanaka, Ryoichi Honda, Masafumi Nojiri, Yuki Sato, Akito Hata, Nobuhisa Ishikawa, Toshiyuki Kozuki, Takahisa Kawamura, Go Saito, Teppei Yamaguchi, Kazuhiro Asada, Satoshi Tetsumoto, Hiroshi Tanaka, Satoshi Watanabe, Yukihiro Umeda, Kakuhiro Yamaguchi, Kazuya Nishii, Kosuke Tsuruno, Yuki Misumi, Hiroshi Kuraishi, Ken Yoshihara, Akira Nakao, Akihito Kubo, Toshihiko Yokoyama, Kana Watanabe, Nobuhiko Seki.


1月30日 船石先生の論文がCancer Chemotherapy and Pharmacologyに掲載されました。

Cancer Chemother Pharmacol. 2025 jan 24. doi:10.1007/s00280-025-04751-2.
HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC
Kunihiko Funaishi, Kakuhiro Yamaguchi, Hiroki Tanahashi, Koji Kurose, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Taku Nakashima, Hiroshi Iwamoto, Hironobu Hamada, Toru Oga, Mikio Oka, Noboru Hattori.